SAN DIEGO--(BUSINESS WIRE)--Dalrada Corporation (OTCQB: DFCO, "Dalrada") is thrilled to announce two new Sòlas Rejuvenation + Wellness locations in Southern California. Through Dalrada Health’s recent acquisition of Remedi Med Spas from previous owner and operator, Dr. Rakhesh Guttikonda, DO, the well-established, award-winning Coronado Island and Mission Hills locations and its highly-skilled staff are now part of the North San Diego-based Sòlas Rejuvenation + Wellness group.
“Dalrada Health is excited to welcome Dr. Guttikonda in an advisory role. His professional insight enables the Company’s continued expansion into multiple industry sectors,” shares Dr. Aboo Nasar, Sòlas Rejuvenation + Wellness group’s Medical Director.
Dr. Rakhesh Guttikonda is a fellowship-trained plastic surgeon specializing exclusively in plastic and reconstructive surgery. Studying natural medicine through his Osteopathic training, Dr. Guttikonda earned his degree from Kansas City University of Medicine and his Biosciences and Internship, Residency, and Fellowship in New York City. His patients benefit from his plastic and reconstructive training knowledge that provides the best and most innovative care.
Dr. Nasar continues, “Combining the Sòlas Rejuvenation + Wellness group’s services with the two new Southern California locations adds a variety of alternative, natural health therapies to plastic and reconstructive surgery treatment options.”
The additional Sòlas Rejuvenation + Wellness locations allow the community's residents access to walk-in treatments from its three convenient state-of-the-art wellness clinics locations at:
Coronado: 171 C Ave. Suite D, Coronado, CA 92118
Mission Hills: 930 West Washington St. Suite 14, San Diego, CA 92103
Poway: 15525 Pomerado Rd. Suite D4, Poway, CA 92064
Dr. Nasar concludes, “The Sòlas Wellness + Rejuvenation group is committed to serving the community, providing innovative health solutions that empower people to thrive, leading healthy lives that they deserve. As Sòlas Wellness + Rejuvenation group continues its expansion, we look forward to sharing the exciting new details.”
For more information on the Sòlas Wellness + Rejuvenation group, please visit www.SolasRejuvenation.com.
Dalrada continuously creates and represents innovative, impactful solutions to address the complex challenges of today and the future. To learn more about Dalrada Corporation and its subsidiaries, please visit www.Dalrada.com.
About Dalrada (DFCO)
Dalrada drives innovation that positively impacts people, businesses, and the planet. With subsidiaries that are firmly positioned in the world’s top three-growing industries of healthcare, clean energy, and technology, Dalrada creates solutions that are sustainable, affordable, and accessible.
The company works continually to produce disruptive products and services that accelerate positive change for current and future generations. Dalrada’s global solutions directly address climate change, post-pandemic gaps in the healthcare industry, and technology solutions for a new era of human behavior and interaction, ensuring a bright future for the world around us.
Established in 1982, Dalrada has since grown its footprint to include the unique business divisions: Dalrada Health, Dalrada Precision, and Dalrada Technologies. For more information, please visit www.dalrada.com.
Disclaimer
Statements in this press release that are not historical facts, the statements are forward-looking, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors and will be dependent upon a variety of factors including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations regarding these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the US Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.
